Nicolas Wolhaupter
Dermatology · Lakeland, FLNPI 1508301011
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $82,962 of the $106,346 with a category attached, or 78.0%. Johnson & Johnson accounts for 65.1% of it on its own, with 23 other manufacturers making up the rest. 2025 is the largest year on record at $34,389, more than ten times the $2,520 reported in 2021. Among dermatology clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 423 payments — averaging $251.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$69K
- Janssen Scientific Affairs, LLC$19K
- Lilly USA, LLC$10K
- AbbVie$2K
- Journey Medical Corporation$2K
- UCB, Inc.$779
- plus $4K from 18 others
What the payments were for
- Consulting fees$9001%
- Speaking & faculty fees$82,96278%
- Travel & lodging$10,11310%
- Food & beverage$11,74111%
- Education$6301%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 151 | $69,185 |
| Janssen Scientific Affairs, LLC | 30 | $19,340 |
| Lilly USA, LLC | 28 | $9,731 |
| AbbVie | 57 | $1,752 |
| Journey Medical Corporation | 6 | $1,658 |
| UCB, Inc. | 27 | $779 |
| Pfizer | 22 | $516 |
| E.r. Squibb & Sons, L.L.C. | 29 | $504 |
| Arcutis Biotherapeutics, Inc. | 7 | $471 |
| Sun Pharmaceutical Industries Inc. | 9 | $454 |
| Novartis | 13 | $359 |
| Botanix SB Inc | 9 | $280 |
| Incyte Corporation | 2 | $207 |
| Regeneron Healthcare Solutions, Inc. | 4 | $202 |
| Galderma Laboratories, L.p. | 4 | $197 |
| Sanofi-aventis U.S. LLC | 2 | $152 |
| Amgen | 5 | $123 |
| Sanofi | 3 | $97 |
| Dermavant Sciences, Inc. | 4 | $85 |
| LEO Pharma Inc. | 3 | $74 |
| Organogenesis Inc. | 1 | $63 |
| Mayne Pharma Commercial LLC | 4 | $60 |
| Almirall LLC | 2 | $45 |
| Genentech USA, Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$106,346 in reported general payments places this provider in the 90th percentile of 1,147 dermatology providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Dupixent PenDupilumab | 22 | $82,849 |
| Dupixent SyringeDupilumab | 14 | $61,767 |
| Fluorouracil | 35 | $2,798 |
| Triamcinolone Acetonide | 94 | $1,073 |
| Ketoconazole | 68 | $879 |
| Doxycycline Hyclate | 60 | $869 |
| Clobetasol Propionate | 19 | $865 |
| Hydrocortisone | 95 | $457 |
| Clindamycin Phosphate | 15 | $372 |
| Ciclopirox | 16 | $363 |
| Nystatin | 13 | $215 |
| Mupirocin | 24 | $152 |
| ValacyclovirValacyclovir Hcl | 11 | $149 |
| Prednisone | 11 | $48 |
Paid to pharmacies, not to this prescriber.
Other dermatology in Lakeland
- Francisco KerdelMiami$2.1M
- Brad GlickMargate$2M
- Robert KirsnerMiami$1.4M
- John MinniStuart$1.4M
- Gil YosipovitchMiami$1M
- Shino Bay AguileraFt Lauderdale$1M
- Robert SnyderPembroke Pines$1M
- Marc IngleseTallahassee$989K
- Jeremy GreenCoral Gables$952K
- Mercedes GonzalezMiami$943K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.